StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
61
This month
1
This year
8
Publishing Date
2024 - 04 - 03
1
2024 - 03 - 27
1
2024 - 03 - 25
1
2024 - 03 - 22
2
2024 - 02 - 26
1
2024 - 02 - 20
1
2024 - 01 - 03
1
2023 - 12 - 27
1
2023 - 12 - 21
1
2023 - 11 - 07
1
2023 - 11 - 01
1
2023 - 10 - 11
1
2023 - 09 - 28
1
2023 - 09 - 27
1
2023 - 09 - 22
1
2023 - 09 - 06
1
2023 - 08 - 22
1
2023 - 08 - 02
1
2023 - 07 - 26
1
2023 - 05 - 11
1
2023 - 05 - 03
1
2023 - 03 - 15
1
2023 - 03 - 08
1
2023 - 03 - 02
1
2023 - 01 - 30
1
2023 - 01 - 23
1
2023 - 01 - 12
1
2022 - 10 - 21
1
2022 - 10 - 19
1
2022 - 08 - 11
1
2022 - 08 - 08
1
2022 - 07 - 25
1
2022 - 05 - 12
1
2022 - 02 - 28
1
2022 - 01 - 25
1
2021 - 12 - 16
1
2021 - 12 - 06
1
2021 - 11 - 18
1
2021 - 11 - 08
1
2021 - 11 - 02
1
2021 - 10 - 25
1
2021 - 10 - 21
1
2021 - 09 - 20
1
2021 - 09 - 14
1
2021 - 09 - 13
1
2021 - 08 - 16
1
2021 - 08 - 10
1
2021 - 08 - 03
1
2021 - 07 - 27
1
2021 - 05 - 10
1
2021 - 04 - 28
1
2021 - 04 - 27
1
2021 - 04 - 08
1
2021 - 03 - 29
1
2021 - 03 - 15
1
2021 - 03 - 01
1
2021 - 01 - 06
1
2021 - 01 - 04
1
2020 - 12 - 07
1
2020 - 12 - 01
1
Sector
Health technology
61
Tags
Agreement
1
America
1
Announces collaboration
1
Antiviral
1
Approval
1
Audio
1
Biopharma
58
Biotech
4
Business
5
Collaboration
2
Conference
18
Designation
1
Direct
1
Disease
2
Drug
3
Earnings
3
Events
3
Fda
3
Financial
6
Financial results
4
Global
1
Growth
1
Icr conference
1
Icr conference 2021
1
Infection
2
Infections
1
Infectious disease
1
Injection
1
Iot
4
Life
1
Life science
1
Liver
2
Mat2203
14
Melanoma
1
Million
1
Money
1
N/a
43
Offering
1
Ongoing
1
Partnerships
1
Patent
1
People
2
Pharm-country
3
Pharmaceutical
1
Phase 1
1
Phase 2
1
Phase 3
1
Pipeline
1
Platform
1
Positive
6
Potential
1
Presentation
5
Program
2
Publication
1
Research
3
Results
20
Technology
3
Treatment
5
Trial
6
Update
11
Entities
22nd century group, inc
110
Actinium pharmaceuticals, inc.
94
Ageagle aerial systems, inc.
62
Alphabet inc.
179
Alpine income property trust, inc.
58
Amarin corporation plc
135
Ambow education holding ltd.
69
American shared hospital services
73
Ampio pharmaceuticals, inc.
92
Annovis bio, inc.
103
Avino silver
60
B2gold corp
133
Barrick gold corporation
56
Biomx inc.
70
Blue ridge bankshares, inc.
63
Caledonia mining corporation plc
158
Can-fite biopharma ltd
80
Centrus energy corp.
67
Cheniere energy, inc.
55
Cormedix inc.
80
Cto realty growth, inc.
64
Daxor corporation
92
Electromed, inc.
68
Energy fuels inc
117
Equinox gold corp.
124
Galiano gold inc.
62
Globalstar, inc.
57
Goldmining inc.
90
Gran tierra energy inc.
75
Great panther mining limited
69
Ibio, inc.
84
Integra resources corp.
64
Johnson & johnson
141
Kaleyra, inc.
64
Lineage cell therapeutics, inc.
109
Matinas biopharma holdings, inc.
61
Maverix metals inc.
56
Milestone scientific, inc.
81
Morphosys ag
177
National healthcare corporation
62
Navidea biopharmaceuticals, inc.
62
Nektar therapeutics
177
New gold inc.
118
Newmont corporation
78
Nexgen energy ltd.
94
Novabay pharmaceuticals, inc.
71
Oncocyte corporation
484
Palatin technologies, inc.
96
Protalix biotherapeutics, inc.
65
Ptc therapeutics, inc.
153
Ring energy, inc.
68
Sifco industries, inc.
118
Silvercorp metals inc.
108
Silvercrest metals inc.
59
Stereotaxis, inc.
62
Taseko mines limited
93
Therapeuticsmd, inc.
178
Trilogy metals inc.
58
Vaxart, inc.
179
Zomedica corp.
64
Symbols
BNTX
10
GILD
2
GMAB
1
GNMSF
1
MTNB
61
SNY
3
SNYNF
2
Exchanges
Amex
61
Nasdaq
13
Crawled Date
2024 - 04 - 03
1
2024 - 03 - 27
1
2024 - 03 - 25
1
2024 - 03 - 22
2
2024 - 02 - 26
1
2024 - 02 - 20
1
2024 - 01 - 03
1
2023 - 12 - 27
1
2023 - 12 - 21
1
2023 - 11 - 07
1
2023 - 11 - 01
1
2023 - 10 - 11
1
2023 - 09 - 28
1
2023 - 09 - 27
1
2023 - 09 - 22
1
2023 - 09 - 06
1
2023 - 08 - 22
1
2023 - 08 - 02
1
2023 - 07 - 26
1
2023 - 05 - 11
1
2023 - 05 - 03
1
2023 - 03 - 15
1
2023 - 03 - 08
1
2023 - 03 - 02
1
2023 - 01 - 30
1
2023 - 01 - 23
1
2023 - 01 - 12
1
2022 - 10 - 21
1
2022 - 10 - 19
1
2022 - 08 - 11
1
2022 - 08 - 08
1
2022 - 07 - 25
1
2022 - 05 - 12
1
2022 - 02 - 28
1
2022 - 01 - 25
1
2021 - 12 - 16
1
2021 - 12 - 06
1
2021 - 11 - 18
1
2021 - 11 - 08
1
2021 - 11 - 02
1
2021 - 10 - 25
1
2021 - 10 - 21
1
2021 - 09 - 20
1
2021 - 09 - 14
1
2021 - 09 - 13
1
2021 - 08 - 16
1
2021 - 08 - 10
1
2021 - 08 - 03
1
2021 - 07 - 27
1
2021 - 05 - 10
1
2021 - 04 - 28
1
2021 - 04 - 27
1
2021 - 04 - 08
1
2021 - 03 - 29
1
2021 - 03 - 15
1
2021 - 03 - 01
1
2021 - 01 - 06
1
2021 - 01 - 04
1
2020 - 12 - 07
1
2020 - 12 - 01
1
Crawled Time
10:41
1
11:00
17
12:00
19
12:03
2
12:30
5
13:00
7
13:30
1
14:00
1
14:20
1
15:00
1
18:00
1
20:00
1
21:00
2
22:00
1
22:01
1
Source
www.biospace.com
17
www.globenewswire.com
44
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Matinas biopharma holdings, inc.
exchanges :
Amex
save search
Matinas BioPharma Prices $10 Million Registered Direct Offering
Published:
2024-04-03
(Crawled : 12:30)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-48.57%
|
O:
-20.29%
H:
0.0%
C:
-18.46%
million
direct
offering
biopharma
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
Published:
2024-03-27
(Crawled : 20:00)
- globenewswire.com
BNTX
|
News
|
$88.19
0.21%
13K
|
Health Technology
|
-5.34%
|
O:
-0.08%
H:
1.01%
C:
-0.7%
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-37.91%
|
O:
-3.38%
H:
2.32%
C:
-3.25%
business
update
biopharma
financial
results
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
Published:
2024-03-25
(Crawled : 12:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-35.25%
|
O:
15.11%
H:
0.0%
C:
-9.31%
positive
biopharma
Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response
Published:
2024-03-22
(Crawled : 13:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-32.38%
|
O:
8.94%
H:
48.28%
C:
-4.14%
mat2203
infection
program
response
Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards
Published:
2024-03-22
(Crawled : 11:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-32.38%
|
O:
8.94%
H:
48.28%
C:
-4.14%
biopharma
Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access Program, Including Multiple Patients with Complete Clinical Resolution
Published:
2024-02-26
(Crawled : 13:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-24.81%
|
O:
1.59%
H:
15.13%
C:
10.61%
mat2203
positive
update
biopharma
Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
Published:
2024-02-20
(Crawled : 12:30)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-21.74%
|
O:
4.35%
H:
11.21%
C:
-0.46%
mat2203
fda
treatment
biopharma
trial
agreement
Matinas BioPharma to Present at Biotech Showcase 2024
Published:
2024-01-03
(Crawled : 12:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-20.0%
|
O:
-2.04%
H:
2.54%
C:
0.05%
biotech
biopharma
Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides
Published:
2023-12-27
(Crawled : 12:30)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-10.8%
|
O:
11.99%
H:
14.6%
C:
7.52%
disease
biopharma
Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA
Published:
2023-12-21
(Crawled : 12:30)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-18.18%
|
O:
2.27%
H:
0.0%
C:
-3.82%
mat2203
fda
update
biopharma
Matinas BioPharma Announces Positive in vivo Efficacy Results of Oral LNC Docetaxel Formulation in a Melanoma Model
Published:
2023-11-07
(Crawled : 13:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-28.46%
|
O:
21.22%
H:
4.92%
C:
4.92%
melanoma
positive
biopharma
results
Matinas BioPharma to Webcast Conference Call to Discuss Third Quarter 2023 Financial Results and Provide a Business Update on November 8, 2023
Published:
2023-11-01
(Crawled : 11:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-17.96%
|
O:
-3.01%
H:
8.04%
C:
-1.88%
conference
business
update
biopharma
financial
results
Patient with Candida krusei Infection in Matinas BioPharma’s Oral MAT2203 Expanded Access Program Achieves Complete Clinical Resolution
Published:
2023-10-11
(Crawled : 12:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
16.13%
|
O:
74.26%
H:
229.51%
C:
137.32%
mat2203
infection
program
Matinas BioPharma to Present at Two Investment Conferences in October 2023
Published:
2023-09-28
(Crawled : 11:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
36.67%
|
O:
2.51%
H:
0.0%
C:
-3.7%
biopharma
Matinas BioPharma to Feature MAT2203 in a Pipeline Presentation at IDWeek
Published:
2023-09-27
(Crawled : 11:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
27.66%
|
O:
-0.71%
H:
5.57%
C:
-5.93%
mat2203
presentation
pipeline
biopharma
Matinas BioPharma Announces Notification of NYSE American Continued Listing Deficiency
Published:
2023-09-22
(Crawled : 21:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
Email alert
Add to watchlist
biopharma
Matinas BioPharma to Participate in the H.C. Wainwright Global Investment Conference
Published:
2023-09-06
(Crawled : 11:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
6.51%
|
O:
4.5%
H:
0.0%
C:
-9.4%
conference
biopharma
global
Matinas BioPharma Announces Publication of Results from the Phase 2 EnACT Clinical Trial of MAT2203 in the IDSA Journal Clinical Infectious Diseases
Published:
2023-08-22
(Crawled : 12:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
9.76%
|
O:
21.95%
H:
0.0%
C:
-19.9%
mat2203
publication
biopharma
trial
results
Matinas BioPharma to Participate in the BTIG Virtual Biotechnology Conference 2023
Published:
2023-08-02
(Crawled : 11:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-49.25%
|
O:
-1.33%
H:
4.29%
C:
-2.57%
conference
biopharma
Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2023 Financial Results and Provide a Business Update on August 9, 2023
Published:
2023-07-26
(Crawled : 12:00)
- globenewswire.com
MTNB
|
$0.1827
1.5%
110K
|
Health Technology
|
-55.0%
|
O:
0.0%
H:
5.0%
C:
2.5%
conference
business
update
biopharma
financial
results
← Previous
1
2
3
4
Next →
Gainers vs Losers
75%
25%
Top 10 Gainers
MTTR
|
News
M
|
$4.625
165.81%
5.5M
|
AGBA
|
$2.615
109.2%
14M
|
Finance
EDBL
|
News
|
$7.37
96.01%
650K
|
PALI
|
$7.64
54.97%
14M
|
Manufacturing
OPRT
|
News
|
$3.19
41.78%
3M
|
Finance
PEGY
|
$0.0629
37.34%
110M
|
Manufacturing
MLEC
|
$1.87
33.57%
1.6M
|
n/a
ATGL
|
$3.66
27.97%
150K
|
KULR
|
$0.5446
22.0%
6.8M
|
Manufacturing
MDIA
4
|
$2.205
21.15%
150K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.